Home / DoD / DoD News: Army Tests Zika Virus Vaccine on Humans

DoD News: Army Tests Zika Virus Vaccine on Humans

HealthThe U.S. Army has conducted clinical trials of an inactivated Zika virus vaccine on 75 human adults at the Walter Reed Army Institute of Research, DoD News reported Tuesday.

Cheryl Pellerin writes WRAIR will test the ZPIV vaccine’s safety and capacity to trigger an immune response in the body as part of Phase 1 trials.

The Army and Defense Department funded WRAIR’s initial trials and the National Institute of Allergy and Infectious Diseases served as sponsor, Pellerin reported.

NIAID also helped identify the viral strain used in ZPIV and supported WRAIR’s preclinical safety testing, DoD News said.

Rhesus monkeys vaccinated with ZPIV developed an immune response against two strains of Zika virus, according to an earlier preclinical study.

WRAIR and NIAID entered a joint research collaboration agreement with the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority to support ZPIV’s development.

The Army agreed to transfer ZPIV technology to Sanofi Pasteur under a cooperative research-and-development agreement.

BARDA awarded a six-year contract to Sanofi Pasteur to further develop ZPIV toward a license.

Check Also

NBIB Continues Background Investigations Amid Government Shutdown

The National Background Investigations Bureau is still running despite the partial government shutdown's effects on the Office of Personnel Management, Nextgov reported Wednesday. The bureau continues to run on funds that customer agencies pay for investigation work. The NBIB has managed to cut a backlog of 725,000 investigations down to 600,000 between April and the end of 2018.

Leave a Reply

Your email address will not be published. Required fields are marked *